1-4 of 4
Jon Arnason
Close
Sort by
Journal Articles

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Clinical Trials & Observations
Inhye E. Ahn, Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker, Robert Black, Josie Montegaard, Alvaro Alencar, Leyla Shune, Mohammad Omaira, Caron A. Jacobson, Philippe Armand, Samuel Y. Ng, Jennifer Crombie, David C. Fisher, Ann S. LaCasce, Jon Arnason, Ephraim P. Hochberg, Ronald W. Takvorian, Jeremy S. Abramson, Jennifer R. Brown, Matthew S. Davids
Journal: Blood Advances
Blood Adv (2024) 8 (4): 832–841.
https://doi.org/10.1182/bloodadvances.2023011574
Published: 2024
Includes: Supplemental data
Journal Articles

A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell–associated neurotoxicity syndrome

Clinical Trials & Observations
Caron A. Jacobson, Allison C. Rosenthal, Jon Arnason, Shirali Agarwal, Peixin Zhang, Wendy Wu, Vian Amber, Jean A. Yared
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6790–6799.
https://doi.org/10.1182/bloodadvances.2023009961
Published: 2023
Includes: Supplemental data
Journal Articles

Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL

Clinical Trials & Observations
Jeremy S. Abramson, Patrick B. Johnston, Manali Kamdar, Sami Ibrahimi, Koji Izutsu, Jon Arnason, Bertram Glass, Pim Mutsaers, Matthew Lunning, Julia Braverman, Fei Fei Liu, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Shien Guo, Ling Shi, Scott R. Solomon
Journal: Blood Advances
Blood Adv (2022) 6 (23): 5969–5979.
https://doi.org/10.1182/bloodadvances.2022008106
Published: 2022
Includes: Supplemental data
Journal Articles

Identification of germline variants in adults with hemophagocytic lymphohistiocytosis

Peter G. Miller, Abhishek Niroula, John J. Ceremsak, Christopher J. Gibson, Martin S. Taylor, Sebastian Birndt, Florian Perner, Jon Arnason, Adam S. Sperling, Mridul Agrawal, Alison M. Schram, Sarah Nikiforow, German Pihan, Robert P. Hasserjian, Jon C. Aster, Paul La Rosée, Elizabeth A. Morgan, Nancy Berliner, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2020) 4 (5): 925–929.
https://doi.org/10.1182/bloodadvances.2019001272
Published: 2020
Includes: Supplemental data